These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22738909)

  • 1. The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
    De Bacco F; Casanova E; Medico E; Pellegatta S; Orzan F; Albano R; Luraghi P; Reato G; D'Ambrosio A; Porrati P; Patanè M; Maderna E; Pollo B; Comoglio PM; Finocchiaro G; Boccaccio C
    Cancer Res; 2012 Sep; 72(17):4537-50. PubMed ID: 22738909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
    Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
    Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target.
    Boccaccio C; Comoglio PM
    Cancer Res; 2013 Jun; 73(11):3193-9. PubMed ID: 23695554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
    Luraghi P; Reato G; Cipriano E; Sassi F; Orzan F; Bigatto V; De Bacco F; Menietti E; Han M; Rideout WM; Perera T; Bertotti A; Trusolino L; Comoglio PM; Boccaccio C
    Cancer Res; 2014 Mar; 74(6):1857-69. PubMed ID: 24448239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
    Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
    Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
    Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.
    Snuderl M; Fazlollahi L; Le LP; Nitta M; Zhelyazkova BH; Davidson CJ; Akhavanfard S; Cahill DP; Aldape KD; Betensky RA; Louis DN; Iafrate AJ
    Cancer Cell; 2011 Dec; 20(6):810-7. PubMed ID: 22137795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.
    Schulte A; Günther HS; Phillips HS; Kemming D; Martens T; Kharbanda S; Soriano RH; Modrusan Z; Zapf S; Westphal M; Lamszus K
    Glia; 2011 Apr; 59(4):590-602. PubMed ID: 21294158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenic and metastatic activity of human thyroid cancer stem cells.
    Todaro M; Iovino F; Eterno V; Cammareri P; Gambara G; Espina V; Gulotta G; Dieli F; Giordano S; De Maria R; Stassi G
    Cancer Res; 2010 Nov; 70(21):8874-85. PubMed ID: 20959469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
    Martens T; Schmidt NO; Eckerich C; Fillbrandt R; Merchant M; Schwall R; Westphal M; Lamszus K
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6144-52. PubMed ID: 17062691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
    Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
    J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.
    Mazzoleni S; Politi LS; Pala M; Cominelli M; Franzin A; Sergi Sergi L; Falini A; De Palma M; Bulfone A; Poliani PL; Galli R
    Cancer Res; 2010 Oct; 70(19):7500-13. PubMed ID: 20858720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
    Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
    Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
    Galimi F; Torti D; Sassi F; Isella C; Corà D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A
    Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET signaling regulates glioblastoma stem cells.
    Joo KM; Jin J; Kim E; Ho Kim K; Kim Y; Gu Kang B; Kang YJ; Lathia JD; Cheong KH; Song PH; Kim H; Seol HJ; Kong DS; Lee JI; Rich JN; Lee J; Nam DH
    Cancer Res; 2012 Aug; 72(15):3828-38. PubMed ID: 22617325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B; Xia S; Abounader R; Laterra J
    Clin Cancer Res; 2005 Jun; 11(12):4479-86. PubMed ID: 15958633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.